Please provide your email address to receive an email when new articles are posted on . In patients with moderate to severe eosinophilic asthma, treatment with dexpramipexole depleted blood and tissue ...

Among adults with moderate to severe asthma receiving rademikibart, those with a high eosinophil count plus high fractional ...

PITTSBURGH--(BUSINESS WIRE)--Knopp Biosciences LLC today reported further clinical and biomarker data demonstrating that reduction in eosinophil count by oral dexpramipexole significantly correlated ...

Elevated absolute eosinophil counts and absolute basophil counts (ABC) are associated with reduced overall survival in essential thrombocythemia. In polycythemia vera, higher ABC correlates with ...

RIVERSIDE, Calif. -- Biomedical scientists at the University of California, Riverside have received a $3.7 million grant from the National Institutes of Health to study the role of sex-specific immune ...

This webinar will reveal new research uncovering intrinsic regulatory mechanisms of eosinophils and highlight an innovative ...

In the EXHALE-4 study, dexpramipexole met the primary endpoint with statistically significant improvement in lung function compared with placebo Dexpramipexole demonstrated statistically significant ...

Areteia Therapeutics Inc., a clinical-stage biotechnology company based in Chapel Hill, has reported positive results from ...

Bhatt’s study, "Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts,” was recently published in The New England Journal of Medicine. Bhatt and colleagues conducted a multicenter ...

Benralizumab, an anti–interleukin-5 receptor alpha monoclonal antibody, was significantly better than placebo at producing a histologic response of up to six eosinophils per high-power field (eos/hpf) ...